Galena Biopharma (GALE) Will Present IHC Data from NeuVax Phase 3 PRESENT at SABCS
Tweet Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced that initial immunohistochemistry (IHC) screening data from the NeuVax (nelipepimut-S) Phase 3 PRESENT (Prevention of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
